Insmed Inc (INSM): Next-Year EPS Estimate 151.54%
As of 2026-09-18, Insmed Inc (INSM) has a next-year EPS growth estimate of 151.54%. Featured in our EPS revision report on 2026-08-07.
On 2026-09-15, analyst consensus for INSM's next-year EPS growth shifted from 157.16% to 151.54% — a negative change of 5.62 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at 75.03%.
What's Driving This
The primary structural driver is the 2026-09-01 upgrade to next-year EPS growth estimates, now at 157.16%, reflecting rising analyst confidence. This upgrade is plausibly connected to Insmed’s Q2 2026 results, where BRINSUPRI surged 49% sequentially, prompting the company to raise its revenue guidance and expand peak sales outlook. The positive earnings headlines and guidance increase support the upward EPS revision. Momentum has continued as the stock keeps rising beyond the initial revision date.
Generated 2026-09-09 from news as of 2026-09-09
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 151.54%
- EPS growth this year
- 75.03%
- EPS next quarter (est)
- -$0.39
- Last price
- $120.00
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-18 | 151.54% | 75.03% | -$0.39 | $120.00 |
| 2026-09-17 | 151.54% | 75.03% | -$0.39 | $123.98 |
| 2026-09-16 | 151.54% | 75.03% | -$0.39 | $122.58 |
| 2026-09-15 | 151.54% | 75.03% | -$0.39 | $119.92 |
| 2026-09-14 | 157.16% | 75.09% | -$0.39 | $125.30 |
| 2026-09-13 | 157.16% | 75.09% | -$0.39 | $129.41 |
| 2026-09-11 | 157.16% | 75.09% | -$0.39 | $129.41 |
| 2026-09-10 | 157.16% | 75.09% | -$0.39 | $127.28 |
| 2026-09-09 | 157.16% | 75.09% | -$0.39 | $128.80 |
| 2026-09-08 | 160.10% | 75.09% | -$0.39 | $124.89 |
| 2026-09-07 | 160.10% | 75.09% | -$0.39 | $126.29 |
| 2026-09-06 | 160.10% | 75.09% | -$0.39 | $126.29 |
| 2026-09-04 | 160.10% | 75.09% | -$0.39 | $126.29 |
| 2026-09-03 | 160.10% | 75.09% | -$0.39 | $126.68 |
| 2026-09-02 | 160.10% | 75.09% | -$0.39 | $126.63 |
| 2026-09-01 | 160.10% | 75.09% | -$0.39 | $121.51 |
| 2026-08-31 | 160.09% | 75.09% | -$0.39 | $121.82 |
| 2026-08-30 | 160.09% | 75.09% | -$0.39 | $118.54 |
| 2026-08-29 | 160.09% | 75.09% | -$0.39 | $118.54 |
| 2026-08-28 | 160.09% | 75.09% | -$0.39 | $118.54 |
| 2026-08-27 | 160.09% | 75.09% | -$0.39 | $121.39 |
| 2026-08-26 | 160.09% | 75.09% | -$0.39 | $124.39 |
| 2026-08-25 | 160.09% | 75.09% | -$0.39 | $123.89 |
| 2026-08-24 | 156.28% | 75.09% | -$0.39 | $123.98 |
| 2026-08-23 | 156.28% | 75.09% | -$0.39 | $125.77 |
| 2026-08-21 | 156.28% | 75.09% | -$0.39 | $125.77 |
| 2026-08-20 | 156.28% | 75.09% | -$0.39 | $125.08 |
| 2026-08-19 | 156.28% | 75.09% | -$0.39 | $130.66 |
| 2026-08-18 | 156.28% | 75.09% | -$0.39 | $128.46 |
| 2026-08-17 | 156.28% | 75.09% | -$0.39 | $128.32 |
Reports Featuring INSM
Recent News
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
- Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global RespiratoryPR Newswire
- Nasdaq-100 Adds New AI and Space Winners. These Stocks Are SoaringGuruFocus.com
Screen Performance
Aggregate stats across all 2047 tickers our top-EPS-revision screen has flagged over the past 170 days.
- Median return since detection
- +0.3%
- % of tickers in the green
- 51%
- Median return on winners
- +22.2%
- Large revisions captured
- 1736
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Insmed Inc's next-year EPS growth estimate?▾
As of 2026-09-18, Insmed Inc (INSM) has a next-year EPS growth estimate of 151.54%, based on analyst consensus.
When was the latest EPS estimate revision for INSM?▾
The most recent revision occurred on 2026-09-15, when analysts adjusted the next-year EPS growth estimate from 157.16% to 151.54%.
What sector and industry does Insmed Inc belong to?▾
Insmed Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INSM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Insmed Inc (INSM) appears here because it was detected by our daily top-EPS-revision-performer screen.